Skip to main content
WLYJohn Wiley & Sons, Inc.Buy Wait6.1·$44.40+0.26%
WLY · Concentration risk · 10-K extracted

John Wiley & Sons (WLY) concentration risks

Updated

The most significant concentration John Wiley & Sons discloses is Research segment at 64%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: John Wiley & Sons’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 3 disclosed concentrations

HIGH1
MEDIUM2
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-inProduct / Revenue mix
64%

Research segment

10-K Item 1: 'Research revenue accounted for approximately 64% of our consolidated revenue in the year ended April 30, 2025'
SEC 10-K · filed Jun 2025
MEDIUMBuilt-inGeographic
49%

outside the US

10-K Item 1: 'approximately 49% of our consolidated revenue was from outside the US'
SEC 10-K · filed Jun 2025
MEDIUMOutside partyCounterparty
46%

professional societies and other publishing partners

10-K Item 1: 'Approximately 46% of Journal Subscriptions revenue is derived from publication rights that are owned by professional societies and other publishing partners'
SEC 10-K · filed Jun 2025
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's concentration profile combines a high-share product tilt, two moderate geographic and counterparty exposures, and a meaningful dependency on third-party content rights. Research revenue accounted for approximately 64% of consolidated revenue in the year ended April 30, 2025 — a large, high-share structural concentration that reflects the deliberate focus on academic and scientific publishing, where recurring subscription revenue is the dominant economic engine. This concentration is structural in character: it flows from the business model rather than reliance on any single buyer. Geographic revenue is more balanced but still leans international: approximately 49% of consolidated revenue was from outside the US, a moderate, medium-share structural exposure that introduces currency translation risk and sensitivity to overseas institutional budgets and open-access mandates. Neither end drives undue single-country risk, but the broad international mix means macro divergence between markets can affect revenue mix year to year. Within the Research segment, approximately 46% of Journal Subscriptions revenue is derived from publication rights owned by professional societies and other publishing partners — a medium-share dependency by disclosed size. If those partners chose to internalize publishing or shift to competing platforms, a meaningful slice of subscription revenue would be at risk. This counterparty dependency deserves monitoring alongside the structural product tilt, as the two together define the core risk profile.

For the engine’s reasoning on WLY’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Publishing

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
WLYJohn Wiley & Sons, Inc.1203
WLYBJohn Wiley & Sons, Inc.1001
NYTNew York Times Company (The)0101

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks WLY Concentration risk
WLY concentration risks — customer, geographic & supplier exposure | TrendMatrix